Company intelligence / Profile preview

Avero Diagnostics

Irving, Texas, United Statesaverodx.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Avero Diagnostics operates as a specialized cancer diagnostics laboratory offering a broad portfolio of anatomic and molecular pathology tests. The company provides subspecialty expertise across breast, gynecologic, dermatopathology, gastrointestinal, urologic, hematologic, molecular, and surgical oncology. Its women’s health division was acquired by Arbor – Women’s Health Elevated in May 2024; the remainder of the business continues under Northwest Pathology since December 2021. No clinical trial results are reported as it does not develop therapeutics.

Therapeutic areas: OncologyHematology
Modalities: Diagnostic testMolecular pathology assayAnatomic pathology assay
Industry: Molecular Diagnostics

Partnerships

Arbor – Women’s Health Elevated

Beyond the preview

Go deeper on Avero Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avero Diagnostics.

Explore the full profile